SHSE:605177 (China)
Â
Class A
Â¥
19.31
(+0.63%)
Nov 29
Business Description
Zhejiang East-Asia Pharmaceutical Co Ltd
Share Class Description:
SHSE:605177: Class ACompare
Compare
Traded in other countries / regions
605177.China IPO Date
2020-11-25Description
Zhejiang East-Asia Pharmaceutical Co Ltd is mainly engaged in the production of bulk pharmaceutical chemicals, tablets, granules and capsules. The company's main products are: Ofloxacin, levofloxacin, loratadine hydrochloride, levofloxacin hydrochloride, trimebutine maleate, ketoconazole, terbinafine hydrochloride, piperazine, ticlazole and so on.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.39 | |||||
| Equity-to-Asset | 0.57 | |||||
| Debt-to-Equity | 0.38 | |||||
| Debt-to-EBITDA | 7.68 | |||||
| Interest Coverage | 27.26 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 1.89 | |||||
| Beneish M-Score | -1.8 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 2.5 | |||||
| 3-Year EBITDA Growth Rate | -3.3 | |||||
| 3-Year EPS without NRI Growth Rate | -9.7 | |||||
| 3-Year Book Growth Rate | 5.2 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 61.85 | |||||
| 9-Day RSI | 56.4 | |||||
| 14-Day RSI | 54.57 | |||||
| 6-1 Month Momentum % | -19.17 | |||||
| 12-1 Month Momentum % | -33.09 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.2 | |||||
| Quick Ratio | 1.21 | |||||
| Cash Ratio | 0.4 | |||||
| Days Inventory | 247.03 | |||||
| Days Sales Outstanding | 50.13 | |||||
| Days Payable | 199.85 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.7 | |||||
| Dividend Payout Ratio | 0.54 | |||||
| Forward Dividend Yield % | 1.7 | |||||
| 5-Year Yield-on-Cost % | 1.71 | |||||
| Shareholder Yield % | -17.74 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 27.28 | |||||
| Operating Margin % | 7.16 | |||||
| Net Margin % | 6.15 | |||||
| FCF Margin % | -25.88 | |||||
| ROE % | 4 | |||||
| ROA % | 2.38 | |||||
| ROIC % | 3.61 | |||||
| ROC (Joel Greenblatt) % | 5.14 | |||||
| ROCE % | 3.62 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 33.88 | |||||
| Forward PE Ratio | 8.69 | |||||
| PE Ratio without NRI | 31.71 | |||||
| PS Ratio | 2.14 | |||||
| PB Ratio | 1.1 | |||||
| Price-to-Tangible-Book | 1.14 | |||||
| EV-to-EBIT | 27.08 | |||||
| EV-to-EBITDA | 27.08 | |||||
| EV-to-Revenue | 2.03 | |||||
| EV-to-FCF | -7.63 | |||||
| Price-to-Graham-Number | 1.27 | |||||
| Price-to-Net-Current-Asset-Value | 16.5 | |||||
| Earnings Yield (Greenblatt) % | 3.69 | |||||
| FCF Yield % | -15.36 | |||||
| Forward Rate of Return (Yacktman) % | -13.76 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zhejiang East-Asia Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,314.975 | ||
| EPS (TTM) (Â¥) | 0.57 | ||
| Beta | 1.03 | ||
| Volatility % | 45.47 | ||
| 14-Day RSI | 54.57 | ||
| 14-Day ATR (Â¥) | 0.56363 | ||
| 20-Day SMA (Â¥) | 18.9465 | ||
| 12-1 Month Momentum % | -33.09 | ||
| 52-Week Range (Â¥) | 14.96 - 29.45 | ||
| Shares Outstanding (Mil) | 114.75 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zhejiang East-Asia Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zhejiang East-Asia Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Zhejiang East-Asia Pharmaceutical Co Ltd Frequently Asked Questions
What is Zhejiang East-Asia Pharmaceutical Co Ltd(SHSE:605177)'s stock price today?
The current price of SHSE:605177 is ¥19.31. The 52 week high of SHSE:605177 is ¥29.45 and 52 week low is ¥14.96.
When is next earnings date of Zhejiang East-Asia Pharmaceutical Co Ltd(SHSE:605177)?
The next earnings date of Zhejiang East-Asia Pharmaceutical Co Ltd(SHSE:605177) is .
Does Zhejiang East-Asia Pharmaceutical Co Ltd(SHSE:605177) pay dividends? If so, how much?
The Dividend Yield %  of Zhejiang East-Asia Pharmaceutical Co Ltd(SHSE:605177) is 1.7% (As of Today), Highest Dividend Payout Ratio of Zhejiang East-Asia Pharmaceutical Co Ltd(SHSE:605177) was 0.83. The lowest was 0.24. And the median was 0.33. The  Forward Dividend Yield % of Zhejiang East-Asia Pharmaceutical Co Ltd(SHSE:605177) is 1.7%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers